Table 3.
Characteristics of ISSNHL based on hearing levels (n = 759 ears, n (%)).
| Characteristics | Mild | Moderate | Moderate to severe | Severe | Profound | Z | P |
|---|---|---|---|---|---|---|---|
| (n = 101) | (n = 103) | (n = 123) | (n = 179) | (n = 253) | |||
| Male | 43 (42.6) | 56 (54.4) | 66 (53.7) | 110 (61.5) | 128 (50.6) | −0.708 | 0.479 |
| Female | 58 (57.4) | 47 (45.6) | 57 (46.3) | 69 (38.5) | 125 (49.4) | ||
| Unilateral hearing loss | 96 (95.0) | 91 (88.3) | 115 (93.5) | 173 (96.6) | 244 (96.4) | −2.125 | 0.034 |
| Bilateral hearing loss | 5 (5.0) | 12 (11.7) | 8 (6.5) | 6 (3.4) | 9 (3.6) | ||
| Accompanying symptoms | |||||||
| Tinnitus | 98 (97.0) | 101 (98.1) | 120 (97.6) | 175 (97.8) | 242 (95.7) | −1.143 | 0.253 |
| Vertigo | 7 (6.9) | 7 (6.8) | 8 (6.5) | 20 (11.2) | 48 (19.0) | −4.266 | 0.000 |
| BPPV | 1 (1.0) | 1 (1.0) | 3 (2.4) | 5 (2.8) | 10 (4.0) | −1.936 | 0.053 |
| comorbidities | |||||||
| Hypertension | 16 (15.8) | 28 (27.2) | 20 (16.3) | 41 (22.9) | 69 (27.3) | −2.06 | 0.039 |
| Diabetes | 0 (0) | 4 (3.9) | 5 (4.1) | 16 (8.9) | 17 (6.7) | −2.55 | 0.011 |
| Abnormal blood coagulation | |||||||
| High fibrinogen | 1 (1.0) | 4 (3.9) | 3 (2.4) | 6 (3.4) | 11 (4.3) | −1.364 | 0.173 |
| Reduced APTT | 3 (3.0) | 5 (4.9) | 5 (4.1) | 11 (6.1) | 19 (7.5) | −1.862 | 0.063 |
| Reduced PT | 2 (2.0) | 6 (5.8) | 1 (0.8) | 1 (0.6) | 5 (2.0) | −1.02 | 0.308 |
| High blood lipid | |||||||
| High TC | 37 (36.6) | 39 (37.9) | 45 (36.6) | 71 (39.7) | 92 (36.4) | −0.089 | 0.929 |
| High TG | 14 (13.9) | 16 (15.5) | 18 (14.6) | 36 (20.1) | 60 (23.7) | −2.709 | 0.007 |
| Low HDL | 31 (30.7) | 45 (43.7) | 50 (40.7) | 69 (38.5) | 113 (44.7) | −1.748 | 0.081 |
| High LDL | 44 (43.6) | 47 (45.6) | 53 (43.1) | 81 (45.3) | 100 (39.5) | −0.997 | 0.319 |
Data were analyzed by non-parametric Mann-Whitney U test.